166 related articles for article (PubMed ID: 37151487)
1. Molecular Modeling and Synthesis of Indoline-2,3-dione-Based Benzene Sulfonamide Derivatives and Their Inhibitory Activity against α-Glucosidase and α-Amylase Enzymes.
Rasheed L; Rehman W; Rahim F; Ali Z; Alanazi AS; Hussain R; Khan I; Alanazi MM; Naseer M; Abdellattif MH; Hussain R; Khan S; Taha M; Ali Shah SA
ACS Omega; 2023 May; 8(17):15660-15672. PubMed ID: 37151487
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
Eur J Med Chem; 2024 Jun; 275():116589. PubMed ID: 38878516
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing
Khan I; Rehman W; Rahim F; Hussain R; Khan S; Rasheed L; Alanazi MM; Alanazi AS; Abdellattif MH
ACS Omega; 2023 Jun; 8(25):22508-22522. PubMed ID: 37396210
[TBL] [Abstract][Full Text] [Related]
4. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations.
Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, In Silico Testing, and In Vitro Evaluation of Thiazolidinone-Based Benzothiazole Derivatives as Inhibitors of α-Amylase and α-Glucosidase.
Khan S; Iqbal S; Khan M; Rehman W; Shah M; Hussain R; Rasheed L; Khan Y; Dera AA; Pashameah RA; Alzahrani E; Farouk AE
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297276
[TBL] [Abstract][Full Text] [Related]
6. Identification of Cyclic Sulfonamides with an
Saddique FA; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Zaki MEA
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056163
[TBL] [Abstract][Full Text] [Related]
7.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
8. Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation.
Ayoup MS; Khaled N; Abdel-Hamid H; Ghareeb DA; Nasr SA; Omer A; Sonousi A; Kassab AE; Eltaweil AS
RSC Adv; 2024 Feb; 14(11):7664-7675. PubMed ID: 38440282
[TBL] [Abstract][Full Text] [Related]
9. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.
Luo S; Zhao L; Peng H; Peng Z; Wang G
Eur J Med Chem; 2024 Jun; 275():116600. PubMed ID: 38889608
[TBL] [Abstract][Full Text] [Related]
10. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents.
Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
12. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.
Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A
BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708
[TBL] [Abstract][Full Text] [Related]
13. Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
Babatunde O; Hameed S; Salar U; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Khan KM; Taha M; Perveen S
Mol Divers; 2022 Apr; 26(2):849-868. PubMed ID: 33650031
[TBL] [Abstract][Full Text] [Related]
14. In Vitro α-Glucosidase and α-Amylase Inhibition, Cytotoxicity and Free Radical Scavenging Profiling of the 6-Halogeno and Mixed 6,8-Dihalogenated 2-Aryl-4-methyl-1,2-dihydroquinazoline 3-Oxides.
Magwaza NM; More GK; Gildenhuys S; Mphahlele MJ
Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001824
[TBL] [Abstract][Full Text] [Related]
15. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
Kothari M; Kannan K; Sahadevan R; Sadhukhan S
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
[TBL] [Abstract][Full Text] [Related]
16. Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity.
Kazempour-Dizaji M; Mojtabavi S; Sadri A; Ghanbarpour A; Faramarzi MA; Navidpour L
Bioorg Chem; 2023 Oct; 139():106709. PubMed ID: 37442042
[TBL] [Abstract][Full Text] [Related]
17. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
[TBL] [Abstract][Full Text] [Related]
18. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity.
Aroua LM; Alosaimi AH; Alminderej FM; Messaoudi S; Mohammed HA; Almahmoud SA; Chigurupati S; Albadri AEAE; Mekni NH
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839780
[TBL] [Abstract][Full Text] [Related]
20. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
